TrialJournal of inherited metabolic disease2017

Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.

Melanie B Gillingham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.